Agios Pharmaceuticals (AGIO) Cash from Operations Growth (1y) (2013 - 2026)
Agios Pharmaceuticals (AGIO) Cash from Operations Growth (1y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,290.43 Bn | 66,290.15 Bn | - | 7.14% |
| 2 | Nanobiotix | 1,914.07 Bn | 1,914.01 Bn | - | - |
| 3 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - | - |
| 4 | BeOne Medicines | 467.97 Bn | 463.18 Bn | 1.35 Bn | 356.73% |
| 5 | Vertex Pharmaceuticals | 122.73 Bn | 115.48 Bn | 2.59 Bn | 74.39% |
| 6 | Regeneron Pharmaceuticals | 70.42 Bn | 61.67 Bn | 3.31 Bn | 3.23% |
| 7 | Belite Bio | 62.82 Bn | 62.82 Bn | - | - |
| 8 | Argenx Se | 56.00 Bn | 50.82 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.51 Bn | 34.50 Bn | 959.66 Mn | 158.60% |
| 10 | Agios Pharmaceuticals | 2.23 Bn | 1.49 Bn | 19.43 Mn | -6.67% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -6.67% |
| Dec 31, 2025 | 27.75% |
| Sep 30, 2025 | -4.67% |
| Jun 30, 2025 | -6.25% |
| Mar 31, 2025 | -11.64% |
| Dec 31, 2024 | -83.71% |
| Sep 30, 2024 | -36.62% |
| Jun 30, 2024 | -8.75% |
| Mar 31, 2024 | -4.92% |
| Dec 31, 2023 | -9.56% |
| Sep 30, 2023 | 13.61% |
| Jun 30, 2023 | 10.08% |
| Mar 31, 2023 | 2.61% |
| Dec 31, 2022 | 21.32% |
| Sep 30, 2022 | 56.49% |
| Jun 30, 2022 | -7.57% |
| Mar 31, 2022 | -8.32% |
| Dec 31, 2021 | -3,156.89% |
| Sep 30, 2021 | -55.93% |
| Jun 30, 2021 | -123.80% |